Theragent is a cell and gene therapy CDMO based in Southern California. H2I Group worked closely with Theragent and Lionakis to develop a lab casework strategy that matched Theragent’s budget and schedule in addition to providing the right fit for their current and future growth needs. The project team successfully adapted to restrictions caused by the COVID-19 pandemic during all phases of the project while maintaining project schedule and quality targets.

H2I Group provided Theragent with mobile casework and an H2I Group Adaptable Legacy Bench System manufactured and designed exclusively for H2I Group and Theragent’s specific laboratory needs.